Valeo Pharma Inc VPHIF

Q3 highlights

[kooter33]

"The third quarter was very much in line with the second quarter after taking into consideration the non-recurrent nature of a number of items impacting our third quarter. We expect to see key operational metrics continuing their improvement and positioning Valeo to exit Q4-2020 as a profitable EBITDA company", added Mr. Mainville.
This statement by the CFO keeps me in the game and wanting more at these prices. YE is Oct 31st 2020.  I will wait to see where this bottoms out before adding.  So much volatility in the markets right now.  Much of that will be settled when the Presidential elections are over and new US President is elected. Who knows when that will occur?

[eric40]

I found this comment by Luc Mainville very interesting too. They must be very confident to set this expectation.  If this materialize, then it should bring Valeo to new level. However, if they miss, it could be ugly.

[kooter33]

agreed! If they miss, it will get ugly.  He seems to be pretty confident that they will be a profitable EBITDA company.  I will take him at his word.  The short count is down significantly as of Oct 1st.  I suspect we will see that fall even further on the Oct 16th update from Shortdata.ca. OCT 1 2020 69 4.805 116,000 4.375 144,918 4

[eric40]

I noticed that too.  From what I know, Luc Mainville is not the kind of guy that would say something like that unless he knows the answer already. I am confident the mood will change with the approval of Redesca.